The Down and Feather Market was valued at USD 8.73 billion in 2025 and is projected to reach USD 15.17 billion by 2033, growing at a CAGR of 7.15% from 2026 to 2033. Market growth is supported by rising consumer demand for premium bedding and apparel products, increasing awareness of natural and sustainable insulation materials, expansion of the hospitality and tourism industries, and heightened focus on sleep quality and thermal comfort in residential and commercial settings.
As per Data Bridge Market Research Analysis the global splice-modulating drug market size was valued at USD 964.00 million in 2025 and is expected to reach USD 4,200.61 million by 2033, at a CAGR of 20.20% during the forecast period
The market growth is largely fueled by the increasing advancements in RNA-targeted therapeutics and growing research focus on gene expression regulation, leading to expanded applications across oncology and rare genetic disorders
Furthermore, rising demand for precision medicine and targeted treatment approaches, along with increasing clinical success of antisense oligonucleotides and small molecule splicing modifiers, is establishing splice-modulating drugs as a transformative therapeutic class. These converging factors are accelerating the adoption of splice-modulating therapies, thereby significantly boosting the industry's growth
Gestational diabetes is a condition in which a woman without diabetes develops high blood sugar levels during pregnancy. It typically occurs during the second or third trimester.
During pregnancy, the placenta produces hormones such as human placental lactogen (hPL). These hormones help the baby grow but also create a "contra-insulin" effect, making the mother's cells more resistant to insulin. If the mother’s pancreas cannot produce enough extra insulin to overcome this resistance, blood glucose levels rise.
Unmanaged GDM can lead to macrosomia (excessive birth weight) and increases the risk of the mother and child developing Type 2 diabetes later in life. Management involves rigorous glucose monitoring, dietary modifications, and sometimes insulin therapy.
